Yufeng Xiao

Also affiliated with Medicina

Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs”.

Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs

Chemical Communications(2020)10.1039/d0cc03243c

N/A

0DataRank · unranked

120 citations

Wei Jia, Lisa Zhao, Xinyi Chen, Guangrong Zheng, Xuan Zhang +2 more

Piperlongumine (PL) conjugates induce targeted protein degradation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.21.474712

N/A

0DataRank · unranked

6 citations

Yufeng Xiao, Xingui Liu, Wanyi Hu, Amin Sobh, Yaxia Yuan +12 more

Piperlongumine conjugates induce targeted protein degradation

Cell chemical biology(2023)10.1016/j.chembiol.2023.01.004

N/A

0DataRank · unranked

71 citations

Yufeng Xiao, Xingui Liu, Wanyi Hu, Amin Sobh, Yaxia Yuan +12 more

HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation

Cell chemical biology(2023)10.1016/j.chembiol.2023.07.010

N/A

0DataRank · unranked

43 citations

Seth Hale, Nikee Awasthee, Chengcheng Meng, Xuan Zhang, Yi Liu +8 more

Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy

Life Medicine(2023)10.1093/lifemedi/lnad019

N/A

0DataRank · unranked

11 citations

Rohan Master, Myung‐Chul Kim, Zeng Jin, Lei Wang, Chandra K. Maharjan +8 more

Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer Immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.09.552650

N/A

0DataRank · unranked

0 citations

Yufeng Xiao, Yuewan Luo, Rohan Master, Jiao Mo, Myung‐Chul Kim +11 more

Targeted Protein Degradation: Current and Emerging Approaches for E3 Ligase Deconvolution

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c00723

N/A

0DataRank · unranked

33 citations

Yaxia Yuan, Yi Liu, Zongtao Lin, Guangrong Zheng, Daohong Zhou +2 more

PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy

The Journal of Experimental Medicine(2024)10.1084/jem.20231519

N/A

0DataRank · unranked

28 citations

Yufeng Xiao, Yuewan Luo, Rohan Master, Jiao Mo, Myung‐Chul Kim +17 more

Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c00761

N/A

0DataRank · unranked

18 citations

Nikee Awasthee, Yi Liu, Chengcheng Meng, Michael Y. He, Seth Hale +8 more

Proteolysis Targeting Chimera Loaded Extracellular Vesicles for Developing Triple Negative Breast Cancer Treatment

Journal of Extracellular Vesicles(2025)10.1002/jev2.70211

N/A

0DataRank · unranked

7 citations

Umasankar De, Yufeng Xiao, Lei Wang, Chandra K. Maharjan, Xiaoshu Pan +7 more

Targeting Lineage-Specific Functions of NR4A1 for Cancer Immunotherapy

International Journal of Molecular Sciences(2025)10.3390/ijms26115266

N/A

0DataRank · unranked

8 citations

Akhila Nataraj, Yufeng Xiao, Bristy Rani Podder, Zeng Jin, Tanzia Islam Tithi +8 more

PROTAC-Mediated Targeting of IKKβ and NR4A1 for AML Therapy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.24.678355

N/A

0DataRank · unranked

0 citations

Yi Liu, Yufeng Xiao, Bristy Rani Podder, Terri Montgomery, Lei Wang +11 more